AHP: Ashawandha Safety Concerns in EU Are Based on Misrepresented Monograph

Bookmark (0)
Please login to bookmark Close

EU health authorities’ calling of ashwagandha’s safety into question is, in part, based on a misrepresentation of AHP’s position on the botanical.

​EU health authorities’ calling of ashwagandha’s safety into question is, in part, based on a misrepresentation of AHP’s position on the botanical. Read More